-
S.African activists push back on data centre rush
-
Billionaire Ambani's Jio jumps 21% in market debut after record India IPO
-
Billionaire Ambani's Jio to debut after record India IPO
-
Sri Lanka's Tamil farmers fight to reclaim land after civil war
-
UK set for cautious budget as borrowing costs climb
-
'They don't care about us': Trump food aid cuts leave Americans struggling and angry
-
US Fed expected to hold rates steady ahead of key midterm elections
-
Palestinian activist Khalil returns to Columbia after US detention
-
AI chip giant SK hynix says quarterly operating profit soars 630%
-
Youths testify about 'despair' in unprecedented Canadian climate trial
-
Charles tackles thorny legacy of slavery on Caribbean trip
-
Storied Paris department store seeks bankruptcy protection
-
UN nuclear watchdog chief urges Iran to grant access
-
Boeing shares tumble after it releases cautious growth forecast
-
Boeing releases cautious growth plan as shares fall sharply
-
Boeing reports smaller loss as it aims for stable output growth
-
Tech firms gain on Anthropic IPO optimism; HSBC slumps in London
-
Dangote, Nigeria's oil tycoon rewriting Africa's story
-
Tech firms track Wall St rally on mixed day for stock markets
-
Kane says Ballon d'Or win 'feels like a dream' as tributes pour in
-
HSBC profit jumps on higher rates, lower costs
-
Mercedes-Benz cuts 2026 profit outlook on tough China market
-
Reparations calls follow Charles on tough Caribbean trip
-
Wall Street faces earnings and Fed tests after turbulent technology-led week
-
China brands drop Mbappe for 'offending national sentiments'
-
Delhi grants minimum monthly pay and DA to about 4,000 MCD health workers
-
Critical coal inventories affect nearly half of India’s domestic power plants
-
FCNR(B) deposit drive puts sharper margin pressure on private banks
-
Gold ETF flows turn negative after 13 weeks as bullion loses 4%
British scientists among winners of top Spanish award
British chemists David Klenerman and Shankar Balasubramanian joined French biophysicist Pascal Mayer in winning Spain's top science award on Wednesday for DNA sequencing research that helped combat coronavirus.
The jury of the Princess of Asturias Awards for scientific and technical research recognised the trio for "driving clinical diagnosis and research in biology, biomedicine, forensic medicine and ecology".
"The sequencing of a complete human genome once required months and millions of euros. Now it can be done in a day and in a way that is thousands of times more cost-effective," the official announcement said.
Thanks to their work, the SARS-CoV2 virus that caused the Covid-19 pandemic was able to be sequenced rapidly, allowing the quicker development of vaccines.
Klenerman and Indian-born Balasubramanian created biotechnology company Solexa, now named Illumina, which developed "a commercial method for genome sequencing that is rapid, cheap and efficient", the foundation said in a statement.
They built on the work of Mayer, who studied "the surface amplification of DNA", a laboratory technique that makes it possible to copy DNA on solid surfaces and facilitate its massive sequencing.
US scientist Mary-Claire King took home last year's prize in this category for her application of genetics to the prevention of cancer, contributing to "saving millions of lives".
Founded in 1981, the Princess of Asturias Awards are the most prestigious in the Spanish-speaking world and are named after the title of the heir to the Spanish throne, Princess Leonor.
They come with 50,000 euros ($58,000) in prize money and a sculpture created by the acclaimed late Catalan artist Joan Miro.
King Felipe VI and Queen Letizia are due to award the prizes at a ceremony in October in the northern city of Oviedo, capital of the Asturias region.
Ng.A.Adebayo--CPN